Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1581"
| Predicate | Value (sorted: none) |
|---|---|
| rdf:type | |
| rdf:type | |
| rdfs:label | |
| ?:Evidence_type | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_value |
"4.64"
|
| dc:creator | |
| dc:date |
"05/09/2012 14:08:12"
|
| ?:content |
"NOTE: The AUC_i/AUC value is calculated from Table 3 using the equation CL=dose/AUC, where CL is the total clearance, and is for all EMs. For PMs, the AUC_i/AUC is 0.83.
route of administration: oral
study duration: 11 days
population: 17 male Dutch volunteers
tested for known CYP450 polymorphisms?
YES -- CYP2D6 phenotyping via sparteine - 9 EMs and 8 PMs
ages: 20-24"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ paroxetine_increases_auc_desipramine, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1329 }